Cardiac ketone body metabolism

Prior research has established that ketone bodies serve as alternative energy sources in carbohydrate-depleted states. It was already known that tissues like the heart can utilize ketones for ATP production. However, the specific role of ketone metabolism in heart disease remains unclear. No prior work had resolved whether ketone body use in heart failure is beneficial or harmful. This gap motivated investigations into how ketones influence cardiac function. That uncertainty drove efforts to understand their signaling effects and metabolic impact. No prior work had resolved the adaptive versus maladaptive nature of ketone metabolism in heart failure. This uncertainty highlights the need for further exploration of ketone body roles in cardiac conditions.

The aim of this review is to examine the current evidence on ketone body metabolism in heart failure. It seeks to clarify whether increased ketone utilization is a compensatory or detrimental process. The specific problem is the lack of consensus on the functional significance of ketone metabolism in heart disease. This study's motivation stems from the observed rise in ketone availability in diabetic and heart failure patients. The goal is to synthesize findings on ketone body signaling and metabolic effects in the heart. It also aims to assess the potential of exogenous ketones as therapeutic agents. This review does not propose new mechanisms but compiles existing data on ketone body roles. It focuses on whether ketone metabolism is a feature of heart failure or a treatment target.

The authors conducted a literature review to evaluate ketone body metabolism in heart failure. They analyzed studies on ketone utilization in cardiac tissues under various conditions. The approach included examining metabolic pathways and signaling effects of ketones in heart disease. They assessed the relationship between ketone concentration and cardiac function in diabetic and heart failure patients. The review focused on how ketones influence ATP production and gene regulation in the heart. They compared findings on ketone body metabolism in normal versus diseased cardiac states. The analysis included data on substrate selection changes in heart failure. The authors did not perform new experiments but synthesized existing evidence on ketone body roles.

Increased ketone body metabolism is a feature of heart failure according to the review. Ketone concentrations rise in diabetes and heart failure, indicating their availability as substrates. The heart utilizes ketones as glucose-sparing energy sources in carbohydrate-depleted states. Ketones act through G-protein coupled receptors and histone deacetylases to regulate gene expression. They influence antioxidant activity and metabolic regulation in cardiac tissues. The review found that ketone metabolism is accompanied by changes in substrate selection in heart failure. Whether these changes are adaptive or maladaptive remains uncertain. The findings suggest a potential role for exogenous ketones in treating the failing heart.

The synthesis of evidence indicates that ketone body metabolism is altered in heart failure. The authors propose that increased ketone use is a feature of cardiac disease but its implications are unclear. They suggest that the heart's shift to ketone metabolism may be a compensatory mechanism. The review highlights the need for further research on the functional significance of ketone metabolism. The authors do not claim that ketone metabolism is essential for heart function. They note that ketone availability increases in diabetes and heart failure, but its effects are uncertain. The possibility of using exogenous ketones to treat heart failure is suggested. The authors emphasize the need for studies to determine whether ketone metabolism is adaptive or harmful.